BYSL and neoplasm: BYSL (Bystin Like, 6p21.1), a direct cMYC target24, is required for nucleologenesis in HCC cell proliferation and its inhibition induces apoptosis, partially arrests the cell cycle and inhibits tumor formation in mouse xenografts25.